The pandemic-starved US Food and Drug Administration facility inspection program is poised to resume full unencumbered operations in the US later this year.
But Acting FDA Commissioner Janet Woodcock told the Senate Appropriations Subcommittee on Agriculture, Rural Development, FDA and Related Agencies that normal foreign
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?